PBM
Income statement / Annual
Last year (2025), Psyence Biomedical Ltd.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Psyence Biomedical Ltd.'s net income was -$6.94 M.
See Psyence Biomedical Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
03/31/2026 |
03/31/2025 |
03/31/2024 |
03/31/2023 |
03/31/2022 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$4.27 K
|
$240.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$4.27 K
|
-$240.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$1.47 M
|
$342.17 K
|
$954.59 K
|
$1.61 M
|
$137.24 K
|
| General & Administrative Expenses |
$4.55 M
|
$0.00
|
$1.72 M
|
$1.62 M
|
$1.70 M
|
| Selling & Marketing Expenses |
$218.49 K
|
$0.00
|
$80.60 K
|
$7.03 K
|
$17.51 K
|
| Selling, General & Administrative Expenses |
$4.77 M
|
$3.32 M
|
$1.80 M
|
$1.63 M
|
$1.72 M
|
| Other Expenses |
$5.27 K
|
$0.00
|
$0.00
|
-$1.94 M
|
-$1.52 M
|
| Operating Expenses |
$6.24 M
|
$3.66 M
|
$2.75 M
|
$1.29 M
|
$334.29 K
|
| Cost And Expenses |
$6.24 M
|
$3.66 M
|
$2.75 M
|
$1.29 M
|
$334.29 K
|
| Interest Income |
$263.37 K
|
$95.79 K
|
$2.13 K
|
$1.55 K
|
$2.42 K
|
| Interest Expense |
$9.52 K
|
$9.27 K
|
$52.94 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$5.27 K
|
$4.27 K
|
$240.00
|
$0.00
|
$2.32 M
|
| EBITDA |
-$6.92 M |
$1.03 M |
-$51.11 M |
$10.77 M |
$10.49 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$698.91 K
|
$4.67 M
|
-$48.41 M
|
$38.50 K
|
$8.56 M
|
| Income Before Tax |
-$6.94 M
|
$1.01 M
|
-$51.16 M
|
$8.01 M
|
$8.23 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$6.94 M
|
$1.01 M
|
-$51.16 M
|
$8.01 M
|
$8.23 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
0 |
1.78 |
-7.85 |
-0.64 |
0.25 |
| EPS Diluted |
0 |
1.78 |
-7.85 |
-0.64 |
0.25 |
| Weighted Average Shares Out |
$0.00
|
$568.02 K
|
$6.52 M
|
$32.67 M
|
$32.67 M
|
| Weighted Average Shares Out Diluted |
$0.00
|
$568.02 K
|
$6.52 M
|
$32.67 M
|
$32.67 M
|
| Link |
|
|
|
|
|
